Tina Vilsbøll

Tina Vilsbøll

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology


Publication year:
All
151 - 160 out of 415Page size: 10
  1. 2017
  2. Published

    Metformin potentiates bile acid-induced GLP-1 secretion in patients with type 2 diabetes

    Bronden, A., Alber, A., Rohde, U., Rehfeld, Jens Frederik, Holst, Jens Juul, Vilsbøll, Tina & Knop, Filip Krag, 2017, In: Diabetologia. 60, p. 113-113 242.

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  3. Published

    Near-normalization of glycaemic control with glucagon-like peptide-1 receptor agonist treatment combined with exercise in patients with type 2 diabetes

    Mensberg, P., Nyby, S., Jørgensen, P. G., Storgaard, H., Jensen, M. T., Sivertsen, J., Holst, Jens Juul, Kiens, Bente, Richter, Erik A., Knop, Filip Krag & Vilsbøll, Tina, 2017, In: Diabetes, Obesity and Metabolism. 19, 2, p. 172-180 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Supportive and non-supportive interactions in families with a type 2 diabetes patient: an integrative review

    Bennich, B. B., Røder, M. E., Overgaard, D., Egerod, Ingrid Eugenie, Munch, L., Knop, Filip Krag, Vilsbøll, Tina & Konradsen, H., 2017, In: Diabetology & Metabolic Syndrome. 9, 10 p., 57.

    Research output: Contribution to journal › Review › Research › peer-review

  5. Published

    THERAPY Liraglutide: preventing or postponing T2DM diagnosis?

    Vilsbøll, Tina & Knop, Filip Krag, 2017, In: Nature Reviews Endocrinology. 13, p. 320-322

    Research output: Contribution to journal › Comment/debate › Research › peer-review

  6. Published

    Use of insulin providers versus insulin sensitizers and risk of out-of-hospital cardiac arrest - a nationwide case-time-control study

    Mohr, G. H., Sondergaard, K. B., Pallisgaard, J. L., Weeke, P., Jensen, Aksel Karl Georg, Rajan, S., Lippert, F. K., Torp-Pedersens, C., Vilsbøll, Tina & Gislason, Gunnar Hilmar, 2017, In: European Heart Journal Supplements. 38, Supplement 1, p. 425-426 2 p.

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  7. Published

    Nonalcoholic Fatty Liver Disease Is Prevalent in Women With Prior Gestational Diabetes Mellitus and Independently Associated With Insulin Resistance and Waist Circumference

    Foghsgaard, S., Andreasen, C., Vedtofte, L., Andersen, E. S., Bahne, E., Strandberg, C., Buhl, T., Holst, Jens Juul, Svare, J. A., Clausen, Tine Dalsgaard, Mathiesen, Elisabeth, Damm, Peter, Gluud, Lise Lotte, Knop, Filip Krag & Vilsbøll, Tina, Jan 2017, In: Diabetes Care. 40, 1, p. 109-116 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    The impact of EndoBarrier gastrointestinal liner in obese patients with normal glucose tolerance and in patients with type 2 diabetes

    Rohde, U., Federspiel, C. A., Vilmann, Peter, Langholz, Ebbe, Friis, S. U., Krakauer, M., Rehfeld, Jens Frederik, Holst, Jens Juul, Vilsbøll, Tina & Knop, Filip Krag, Feb 2017, In: Diabetes, Obesity and Metabolism. 19, 2, p. 189-199 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Use of antibiotics in childhood and risk of Type 1 diabetes: a population-based case-control study

    Mikkelsen, K. H., Knop, Filip Krag, Vilsbøll, Tina, Frost, M., Hallas, J. & Pottegård, A., Feb 2017, In: Diabetic Medicine. 34, 2, p. 272–277

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Efficacy and safety of fixed-ratio combination of insulin degludec and liraglutide (IDegLira) for the treatment of type 2 diabetes

    Vedtofte, L., Knop, Filip Krag & Vilsbøll, Tina, Mar 2017, In: Expert Opinion on Drug Safety. 16, 3, p. 387-396 10 p.

    Research output: Contribution to journal › Review › Research › peer-review

  11. Published

    A Fixed Ratio Combination of Insulin Degludec and Liraglutide (IDegLira) Reduces Glycemic Fluctuation and Brings More Patients with Type 2 Diabetes Within Blood Glucose Target Ranges

    King, A. B., Philis-Tsimikas, A., Kilpatrick, E. S., Langbakke, I. H., Begtrup, K. & Vilsbøll, Tina, Apr 2017, In: Diabetes Technology & Therapeutics. 19, 4, p. 255-264 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1...12 13 14 15 16 17 18 19 ...42 Next

ID: 33056950